All Stories

  1. Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man

    Article • Frontiers in Pharmacology, May 2020, Frontiers

    Rafel Simó Vicens

  2. The KCa2 Channel Inhibitor AP14145, But Not Dofetilide or Ondansetron, Provides Functional Atrial Selectivity in Guinea Pig Hearts

    Article • Frontiers in Pharmacology, June 2019, Frontiers

    Rafel Simó Vicens

  3. 2,6-Bis(2-Benzimidazolyl)Pyridine (BBP) Is a Potent and Selective Inhibitor of Small Conductance Calcium-Activated Potassium (SK) Channels

    Article • Frontiers in Pharmacology, December 2018, Frontiers

    Rafel Simó Vicens

  4. A new negative allosteric modulator, AP14145, for the study of small conductance calcium‐activated potassium (KCa2) channels

    Article • British Journal of Pharmacology, October 2017, Wiley

    Rafel Simó Vicens

  5. Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca 2+ -Activated K + Channels in Pigs

    Article • Circulation Arrhythmia and Electrophysiology, October 2017, Wolters Kluwer Health

    Rafel Simó Vicens

  6. Effect of antiarrhythmic drugs on small conductance calcium – activated potassium channels

    Article • European Journal of Pharmacology, May 2017, Elsevier

    Rafel Simó Vicens

  7. C-PO02-01 to C-PO02-220

    Article • Heart Rhythm, May 2017, Elsevier

    Rafel Simó Vicens